ARCHIVES

NCI begins rewrite of cancer center grant guidelines; will allow clinical investigator support. Goal is to implement P30-P50 working group recommendations, simplify guidelines, Karen Antman tells advisory board.

This article is from The Cancer Letter archive.

Vol. 30 No. 12 | March 19, 2004

Download PDF Visit The Full Archive

Related Articles

Study: BRCA2-Negative Women Could Still Have High Risk

December 27, 2013

Clinical Oncology Grant Funding: The History Of a Controversy

July 23, 1993

Conversation With The Cancer Letter: How ASCO’s Guideline Differs—And Why

July 20, 2012

In Brief: Rosenberg To Give Karnofsky Lecture at ASCO, Minna To Present Rosenthal Lecture At AACR

April 27, 1984

FDA Approves New Toxicology Protocol; Drug Program Under Fire; DCT Board Approves Cutbacks, Contract Concepts

October 9, 1981

Tamoxifen: No Mortality Benefit For Most “High Risk” Women

September 29, 2006